| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 230,416 | 244,447 | 287,133 | 256,129 | | Cost of Revenue | 198,108 | 217,754 | 270,978 | 238,178 | | | Gross Profit | 32,308 | 26,693 | 16,155 | 17,951 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,612 | 15,886 | 16,265 | 15,980 | | Non Recurring |
-
| 55,667 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (27,385) | (44,860) | (110) | 1,971 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (27,385) | (44,860) | (110) | 1,971 | | Interest Expense | 12,294 | 10,749 | 8,192 | 10,846 | | Income Before Tax | (39,679) | (55,609) | (8,302) | (8,875) | | Income Tax Expense | (4,709) | (4,840) | (1,324) | (4,544) | | Minority Interest | (134) | 687 | 351 | 568 | | | | Net Income From Continuing Ops | (35,395) | (50,539) | (6,878) | (3,329) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,686 | (50,539) | (6,878) | (3,329) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,686 | ($50,539) | ($6,878) | ($3,329) |
|
0.51% Nasdaq 
Income Statement
